209 related articles for article (PubMed ID: 34801826)
1. Structure-based screening combined with computational and biochemical analyses identified the inhibitor targeting the binding of DNA Ligase 1 to UHRF1.
Kori S; Shibahashi Y; Ekimoto T; Nishiyama A; Yoshimi S; Yamaguchi K; Nagatoishi S; Ohta M; Tsumoto K; Nakanishi M; Defossez PA; Ikeguchi M; Arita K
Bioorg Med Chem; 2021 Dec; 52():116500. PubMed ID: 34801826
[TBL] [Abstract][Full Text] [Related]
2. Structure of the UHRF1 Tandem Tudor Domain Bound to a Methylated Non-histone Protein, LIG1, Reveals Rules for Binding and Regulation.
Kori S; Ferry L; Matano S; Jimenji T; Kodera N; Tsusaka T; Matsumura R; Oda T; Sato M; Dohmae N; Ando T; Shinkai Y; Defossez PA; Arita K
Structure; 2019 Mar; 27(3):485-496.e7. PubMed ID: 30639225
[TBL] [Abstract][Full Text] [Related]
3. Structural insight into coordinated recognition of trimethylated histone H3 lysine 9 (H3K9me3) by the plant homeodomain (PHD) and tandem tudor domain (TTD) of UHRF1 (ubiquitin-like, containing PHD and RING finger domains, 1) protein.
Cheng J; Yang Y; Fang J; Xiao J; Zhu T; Chen F; Wang P; Li Z; Yang H; Xu Y
J Biol Chem; 2013 Jan; 288(2):1329-39. PubMed ID: 23161542
[TBL] [Abstract][Full Text] [Related]
4. Serine 298 Phosphorylation in Linker 2 of UHRF1 Regulates Ligand-Binding Property of Its Tandem Tudor Domain.
Kori S; Jimenji T; Ekimoto T; Sato M; Kusano F; Oda T; Unoki M; Ikeguchi M; Arita K
J Mol Biol; 2020 Jun; 432(14):4061-4075. PubMed ID: 32428527
[TBL] [Abstract][Full Text] [Related]
5. The histone and non-histone methyllysine reader activities of the UHRF1 tandem Tudor domain are dispensable for the propagation of aberrant DNA methylation patterning in cancer cells.
Vaughan RM; Kupai A; Foley CA; Sagum CA; Tibben BM; Eden HE; Tiedemann RL; Berryhill CA; Patel V; Shaw KM; Krajewski K; Strahl BD; Bedford MT; Frye SV; Dickson BM; Rothbart SB
Epigenetics Chromatin; 2020 Oct; 13(1):44. PubMed ID: 33097091
[TBL] [Abstract][Full Text] [Related]
6. Discovery of Small-Molecule Antagonists of the H3K9me3 Binding to UHRF1 Tandem Tudor Domain.
Senisterra G; Zhu HY; Luo X; Zhang H; Xun G; Lu C; Xiao W; Hajian T; Loppnau P; Chau I; Li F; Allali-Hassani A; Atadja P; Oyang C; Li E; Brown PJ; Arrowsmith CH; Zhao K; Yu Z; Vedadi M
SLAS Discov; 2018 Oct; 23(9):930-940. PubMed ID: 29562800
[TBL] [Abstract][Full Text] [Related]
7. Methylation of DNA Ligase 1 by G9a/GLP Recruits UHRF1 to Replicating DNA and Regulates DNA Methylation.
Ferry L; Fournier A; Tsusaka T; Adelmant G; Shimazu T; Matano S; Kirsh O; Amouroux R; Dohmae N; Suzuki T; Filion GJ; Deng W; de Dieuleveult M; Fritsch L; Kudithipudi S; Jeltsch A; Leonhardt H; Hajkova P; Marto JA; Arita K; Shinkai Y; Defossez PA
Mol Cell; 2017 Aug; 67(4):550-565.e5. PubMed ID: 28803780
[TBL] [Abstract][Full Text] [Related]
8. The finger loop of the SRA domain in the E3 ligase UHRF1 is a regulator of ubiquitin targeting and is required for the maintenance of DNA methylation.
Vaughan RM; Rothbart SB; Dickson BM
J Biol Chem; 2019 Oct; 294(43):15724-15732. PubMed ID: 31481468
[TBL] [Abstract][Full Text] [Related]
9. Molecular investigation of the tandem Tudor domain and plant homeodomain histone binding domains of the epigenetic regulator UHRF2.
Ginnard SM; Winkler AE; Mellado Fritz C; Bluhm T; Kemmer R; Gilliam M; Butkevich N; Abdrabbo S; Bricker K; Feiler J; Miller I; Zoerman J; El-Mohri Z; Khuansanguan P; Basch M; Petzold T; Kostoff M; Konopka S; Kociba B; Gillis T; Heyl DL; Trievel RC; Albaugh BN
Proteins; 2022 Mar; 90(3):835-847. PubMed ID: 34766381
[TBL] [Abstract][Full Text] [Related]
10. Biochemical and dynamic basis for combinatorial recognition of H3R2K9me2 by dual domains of UHRF1.
Abhishek S; Nivya MA; Nakarakanti NK; Deeksha W; Khosla S; Rajakumara E
Biochimie; 2018 Jun; 149():105-114. PubMed ID: 29656054
[TBL] [Abstract][Full Text] [Related]
11. An Intramolecular Interaction of UHRF1 Reveals Dual Control for Its Histone Association.
Gao L; Tan XF; Zhang S; Wu T; Zhang ZM; Ai HW; Song J
Structure; 2018 Feb; 26(2):304-311.e3. PubMed ID: 29395786
[TBL] [Abstract][Full Text] [Related]
12. Tandem virtual screening targeting the SRA domain of UHRF1 identifies a novel chemical tool modulating DNA methylation.
Myrianthopoulos V; Cartron PF; Liutkevičiūtė Z; Klimašauskas S; Matulis D; Bronner C; Martinet N; Mikros E
Eur J Med Chem; 2016 May; 114():390-6. PubMed ID: 27049577
[TBL] [Abstract][Full Text] [Related]
13. Discovery of small molecules targeting the tandem tudor domain of the epigenetic factor UHRF1 using fragment-based ligand discovery.
Chang L; Campbell J; Raji IO; Guduru SKR; Kandel P; Nguyen M; Liu S; Tran K; Venugopal NK; Taylor BC; Holt MV; Young NL; Samuel ELG; Jain P; Santini C; Sankaran B; MacKenzie KR; Young DW
Sci Rep; 2021 Jan; 11(1):1121. PubMed ID: 33441849
[TBL] [Abstract][Full Text] [Related]
14. Refined read-out: The hUHRF1 Tandem-Tudor domain prefers binding to histone H3 tails containing K4me1 in the context of H3K9me2/3.
Choudalakis M; Kungulovski G; Mauser R; Bashtrykov P; Jeltsch A
Protein Sci; 2023 Sep; 32(9):e4760. PubMed ID: 37593997
[TBL] [Abstract][Full Text] [Related]
15. Conformational dynamics of the TTD-PHD histone reader module of the UHRF1 epigenetic regulator reveals multiple histone-binding states, allosteric regulation, and druggability.
Houliston RS; Lemak A; Iqbal A; Ivanochko D; Duan S; Kaustov L; Ong MS; Fan L; Senisterra G; Brown PJ; Wang YX; Arrowsmith CH
J Biol Chem; 2017 Dec; 292(51):20947-20959. PubMed ID: 29074623
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of UHRF1, associated with re-expression of tumor suppressor genes, is a common feature of natural compounds exhibiting anti-cancer properties.
Alhosin M; Sharif T; Mousli M; Etienne-Selloum N; Fuhrmann G; Schini-Kerth VB; Bronner C
J Exp Clin Cancer Res; 2011 Apr; 30(1):41. PubMed ID: 21496237
[TBL] [Abstract][Full Text] [Related]
17. Inhibitors of UHRF1 base flipping activity showing cytotoxicity against cancer cells.
Ciaco S; Mazzoleni V; Javed A; Eiler S; Ruff M; Mousli M; Mori M; Mély Y
Bioorg Chem; 2023 Aug; 137():106616. PubMed ID: 37247564
[TBL] [Abstract][Full Text] [Related]
18. UHRF1 Induces Methylation of the
Kim MJ; Lee HJ; Choi MY; Kang SS; Kim YS; Shin JK; Choi WS
Mol Cells; 2021 Mar; 44(3):146-159. PubMed ID: 33795533
[TBL] [Abstract][Full Text] [Related]
19. Novel compound heterozygous mutations in UHRF1 are associated with atypical immunodeficiency, centromeric instability and facial anomalies syndrome with distinctive genome-wide DNA hypomethylation.
Unoki M; Velasco G; Kori S; Arita K; Daigaku Y; Yeung WKA; Fujimoto A; Ohashi H; Kubota T; Miyake K; Sasaki H
Hum Mol Genet; 2023 Apr; 32(9):1439-1456. PubMed ID: 36458887
[TBL] [Abstract][Full Text] [Related]
20. Discovery and Mechanism of Small Molecule Inhibitors Selective for the Chromatin-Binding Domains of Oncogenic UHRF1.
Liu WH; Miner RE; Albaugh BN; Ananiev GE; Wildman SA; Denu JM
Biochemistry; 2022 Mar; 61(5):354-366. PubMed ID: 35143176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
